AS1411 aptamer-targeted Gold Nanoclusters Effect on the Enhancement of Radiation Therapy Efficacy in Breast tumor-bearing Mice
The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
AIM: Herein, the AS1411 aptamer-targeted ultrasmall gold nanoclusters (GNCs) were assessed at different aspects as a radiosensitizer. MATERIALS & METHODS: AS1411 aptamer-conjugated gold nanoclusters (Apt-GNCs) efficacy was evaluated at cancer cells targeting, radiosensitizing effect, tumor targeting, and biocompatibility in breast tumor-bearing mice. RESULTS: Flow cytometry and fluorescence microscopy exhibited more cellular uptake for Apt-GNCs in comparison with GNCs. In addition, inductively coupled plasma optical emission spectrometry results demonstrated its effective tumor targeting as the tumors' gold content for GNCs and Apt-GNCs were 8.53 and 15.33 μg/g, respectively. Apt-GNCs significantly enhanced radiotherapy efficacy as mean tumors' volume decreased about 39% and 9 days increase in the mice survival was observed. Both GNCs and Apt-GNCs were biocompatible. CONCLUSION: The Apt-GNCs is a novel and efficient radiosensitizer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies reported radiosensitization metrics such as dose enhancement factors or sensitizer enhancement ratios (SER), indicating increased radiation response in the presence of nanoparticles [24,27,64].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [64]
Citations
Cites
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
The use of gold nanoparticles to enhance radiotherapy in mice
Hainfeld, J. F., Slatkin, D. N., & Smilowitz, H. M. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/18/n03 · Cited by 1,638
Pulaski, B. A., & Ostrand‐Rosenberg, S. (2000) · Current Protocols in Immunology · doi:10.1002/0471142735.im2002s39 · Cited by 912
Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy
Chithrani, D. B., Jelveh, S., Jalali, F., van Prooijen, M., Allen, C., Bristow, R. G., Hill, R. P., & Jaffray, D. A. (2010) · Radiation Research · doi:10.1667/rr1984.1 · Cited by 669
Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice
Lasagna-Reeves, C., Gonzalez-Romero, D., Barria, M. A., Olmedo, I., Clos, A., Sadagopa Ramanujam, V. M., Urayama, A., Vergara, L., Kogan, M. J., & Soto, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.046 · Cited by 584
The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
Soundararajan, S., Chen, W., Spicer, E. K., Courtenay-Luck, N., & Fernandes, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5723 · Cited by 512
Discovery and development of anticancer aptamers
Ireson, C. R., & Kelland, L. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0172 · Cited by 481
Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation Energies
Jain, S., Coulter, J. A., Hounsell, A. R., Butterworth, K. T., McMahon, S. J., Hyland, W. B., Muir, M. F., Dickson, G. R., Prise, K. M., Currell, F. J., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.08.044 · Cited by 475
Gold nanoparticles for cancer radiotherapy: a review
Haume, K., Rosa, S., Grellet, S., Śmiałek, M. A., Butterworth, K. T., Solov’yov, A. V., Prise, K. M., Golding, J., & Mason, N. J. (2016) · Cancer Nanotechnology · doi:10.1186/s12645-016-0021-x · Cited by 445
Research works printed but not linked: 1
- 10.1088/0031-9155/49/18/n03 · DOI · Paper page
Cited by
Therapeutic applications of AS1411 aptamer, an update review
Yazdian-Robati, R., Bayat, P., Oroojalian, F., Zargari, M., Ramezani, M., Taghdisi, S. M., & Abnous, K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.118 · Cited by 288
“The results of this study confirmed the potential of Aptamer–GNCs in improving the outcome of tumor radiotherapy [122].”
ResultG-Quadruplex-Forming Aptamers—Characteristics, Applications, and Perspectives
Roxo, C., Kotkowiak, W., & Pasternak, A. (2019) · Molecules · doi:10.3390/molecules24203781 · Cited by 207
Atomically Precise Gold–Levonorgestrel Nanocluster as a Radiosensitizer for Enhanced Cancer Therapy
Jia, T.-T., Yang, G., Mo, S.-J., Wang, Z.-Y., Li, B.-J., Ma, W., Guo, Y.-X., Chen, X., Zhao, X., Liu, J.-Q., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b03767 · Cited by 184
Aptamers as an approach to targeted cancer therapy
Mahmoudian, F., Ahmari, A., Shabani, S., Sadeghi, B., Fahimirad, S., & Fattahi, F. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03295-4 · Cited by 143
Zare, I., Chevrier, D. M., Cifuentes‐Rius, A., Moradi, N., Xianyu, Y., Ghosh, S., Trapiella‐Alfonso, L., Tian, Y., Shourangiz-Haghighi, A., Mukherjee, S., et al. (2021) · Materials Today · doi:10.1016/j.mattod.2020.10.027 · Cited by 135
Aptamers in biomedicine: Selection strategies and recent advances
Ștefan, G., Hosu, O., Wael, K. D., Lobo-Castañón, M. J., & Cristea, C. (2021) · Electrochimica Acta · doi:10.1016/j.electacta.2021.137994 · Cited by 120
Functional Aptamer-Embedded Nanomaterials for Diagnostics and Therapeutics
Xie, S., Ai, L., Cui, C., Fu, T., Cheng, X., Qu, F., & Tan, W. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c19562 · Cited by 108
An overview and future prospects on aptamers for food safety
Schmitz, F. R. W., Valério, A., de Olíveira, D., & Hotza, D. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10747-0 · Cited by 106
“The AS1411 aptamer conjugated with gold nanoclusters was tested in mice cancer cells and demonstrated to be a good radiosensitizer (Ghahremani et al. 2018).”
Recent Advances in Nanomaterials Development for Nanomedicine and Cancer
Kajani, A. A., Javanmard, S. H., Asadnia, M., & Razmjou, A. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00591 · Cited by 102
Lin, Z., Goswami, N., Xue, T., Chai, O. J. H., Xu, H., Liu, Y., Su, Y., & Xie, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202105662 · Cited by 90
Metal nanocluster-based hybrid nanomaterials: Fabrication and application
Yang, J., Peng, Y., Li, S., Mu, J., Huang, Z., Ma, J., Shi, Z., & Jia, Q. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214391 · Cited by 78
Mahdevar, E., Safavi, A., Abiri, A., Kefayat, A., Hejazi, S. H., Miresmaeili, S. M., & Mobarakeh, V. I. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1883111 · Cited by 73
Self-citationDrozdov, A. S., Nikitin, P. I., & Rozenberg, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313011 · Cited by 67
Khan, I. M., Niazi, S., Akhtar, W., Yue, L., Pasha, I., Khan, M. K. I., Mohsin, A., Iqbal, M. W., Zhang, Y., & Wang, Z. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214842 · Cited by 62
Recent Metal Nanotheranostics for Cancer Diagnosis and Therapy: A Review
Khorasani, A., Shahbazi‐Gahrouei, D., & Safari, A. (2023) · Diagnostics · doi:10.3390/diagnostics13050833 · Cited by 62
Self-citationKefayat, A., Ghahremani, F., Motaghi, H., & Mehrgardi, M. A. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.01.037 · Cited by 54
Self-citationShahbazi‐Gahrouei, D., Choghazardi, Y., Kazemzadeh, A., Naseri, P., & Shahbazi‐Gahrouei, S. (2023) · IET Nanobiotechnology · doi:10.1049/nbt2.12134 · Cited by 50
“This has been attained, for example, with antibodies [64], peptides [65], folates [66], and aptamers [67].”
BackgroundSelf-citationAptamer-Mediated Nanotheranostics for Cancer Treatment: A Review
Ravichandran, G., & Rengan, A. K. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c01785 · Cited by 48
Shahbazi‐Gahrouei, D., Khaniabadi, P. M., Khaniabadi, B. M., Shahbazi‐Gahrouei, S., & Fazel, M. (2019) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_437_18 · Cited by 45
“Journal of Research in Medical Sciences | 2019 | 4 under in vitro conditions and their cytotoxicity was investigated.[5,36] In this way, Keshtkar et al.”
Self-citationKefayat, A., Hosseini, M., Ghahremani, F. H., Jolfaie, N. A., & Rafienia, M. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01380-2 · Cited by 45
“The sections were stained with Hematoxylin & Eosin (H&E) staining protocol according to previous studies [57, 70].”
MethodSelf-citationQayyum, A., Batool, Z., Fatima, M., Buzdar, S. A., Ullah, H., Nazir, A., Jabeen, Q., Siddique, S., & Imran, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-17332-7 · Cited by 40
Safavi, A., Kefayat, A., Mahdevar, E., Ghahremani, F. H., Nezafat, N., & Modarressi, M. H. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1763693 · Cited by 39
“The sections were stained by Hematoxylin & Eosin (H&E) protocol.(60,61) The slides were reviewed by an expert pathologist under a light microscope (Olympus, Japan)and histological photographs were obtained.”
MethodSelf-citationZhao, J., Li, D., Ma, J., Yang, H., Chen, W., Cao, Y., & Liu, P. (2021) · Nanotechnology · doi:10.1088/1361-6528/abd20a · Cited by 35
“This could be due to AS1411 speci fi cally recognizing the nuleolin overexpressed on the plasma membrane of tumor cells, thereby enhancing cellular uptake via receptor-mediated endocytosis [ 36, 37 ] .”
Aptamers as target-specific recognition elements in drug delivery
Vydaline, A. O. E., Rozhkov, S., Sosa, G., & Mallikaratchy, P. R. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115685 · Cited by 37
Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma
Li, Q., Maier, S. H., Li, P., Peterhansl, J., Belka, C., Mayerle, J. V., & Mahajan, U. M. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01624-1 · Cited by 36
Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy
Lee, M., Lee, M.-J., Song, Y., Kim, S., & Park, N. (2024) · Molecules · doi:10.3390/molecules29194737 · Cited by 35
Recent nanotheranostics applications for cancer therapy and diagnosis: A review
Aminolroayaei, F., Shahbazi‐Gahrouei, D., Shahbazi‐Gahrouei, S., & Rasouli, N. (2021) · IET Nanobiotechnology · doi:10.1049/nbt2.12021 · Cited by 34
“Gold nanoparticles do not have such cytotoxicity and can be used for MR, photoacoustic, fluorescence, and X‐ray scattering imaging [30, 31].”
BackgroundSelf-citationAptamers as a new frontier in targeted cancer therapy
Li, Y., Zamay, T. N., Luzan, N. A., Pryakhin, E. A., Владимировна, С. Е., Osminkina, L. A., Kolovskaya, O. S., Dymova, M. A., Kuligina, E. V., Richter, V. A., et al. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115692 · Cited by 32
Maghsoudi, S., Shahraki, B. T., Rabiee, N., Afshari, R., Fatahi, Y., Dinarvand, R., Ahmadi, S., Bagherzadeh, M., Rabiee, M., Tayebi, L., et al. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101146 · Cited by 31
“Apt–GNCs: Aptamer-conjugated gold Nano-clusters; BSA: Bovine serum albumin [45].”
BackgroundYang, Z., Yang, A., Ma, W., Ma, K., Lv, Y., Peng, P., Zang, S., & Li, B. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01207-6 · Cited by 29
“For example, researchers have developed NCs that could make cancer cells more sensitive to radiation and promote the efficiency of radiotherapy [27–30].”
BackgroundTan, K. X., Jeevanandam, J., Pan, S., Yon, L. S., & Danquah, M. K. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101764 · Cited by 28
Shakibapour, M., Kefayat, A., Mofid, M. R., Shojaie, B., Mohamadi, F., Sharafi, S. M., Mahmoudzadeh, M., & Darani, H. Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107955 · Cited by 27
Self-citationA literature review on multimodality molecular imaging nanoprobes for cancer detection
Shahbazi‐Gahrouei, D., Khaniabadi, P. M., Shahbazi‐Gahrouei, S., Khorasani, A., & Mahmoudi, F. (2019) · Polish Journal of Medical Physics And Engineering · doi:10.2478/pjmpe-2019-0009 · Cited by 25
Self-citationDesign of a gold clustering site in an engineered apo-ferritin cage
Lu, C., Maity, B., Xue, P., Ito, N., Abe, S., Sheng, X., Ueno, T., & Lu, D. (2022) · Communications Chemistry · doi:10.1038/s42004-022-00651-1 · Cited by 24
pH-responsive graphene oxide loaded with targeted peptide and anticancer drug for OSCC therapy
Li, R., Gao, R., Zhao, Y., Zhang, F., Wang, X., Li, B., Wang, L., Ma, L., & Du, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.930920 · Cited by 23
Saidi, D., Obeidat, M., Alsotari, S. T., Ibrahim, A. A., Albuqain, R., Wehaibi, S., Alqudah, D. A., Nsairat, H., Alshaer, W., & Alkilany, A. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30743 · Cited by 18
Vivo-Llorca, G., Morellá‐Aucejo, Á., García-Fernández, A., Díez, P., Llopis‐Lorente, A., Orzáez, M., & Martínez‐Máñez, R. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s323802 · Cited by 18
RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities
Wang, S., Sun, H., Chen, G., Wu, C., Sun, B., Lin, J., Lin, D., Zeng, D., Lin, B., Huang, G., et al. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104271 · Cited by 15
Recent advancements in aptamers as promising nanotool for therapeutic and diagnostic applications
Alsaidan, O. A. (2025) · Analytical Biochemistry · doi:10.1016/j.ab.2025.115844 · Cited by 15
Fang, T., Duan, Z., Wan, N., Zuo, X., Pan, Z., Zhang, W., Ge, F., & Gui, L. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c02074 · Cited by 14
Yaghoobi, F., Shervedani, R. K., Torabi, M., Kefayat, A., Ghahremani, F. H., & Farzadniya, A. (2019) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2019.123917 · Cited by 13
Self-citationChen, Z., Deng, X.-H., Jiang, C., Wang, J., Li, W., Zhu, K.-L., Li, Y., Song, B., & Zhang, Z. (2023) · The American Journal of Sports Medicine · doi:10.1177/03635465231159668 · Cited by 12
Xue, A., & Fan, S. (2022) · Biomolecules · doi:10.3390/biom12060821 · Cited by 12
The Role of Gold Nanoclusters as Emerging Theranostic Agents for Cancer Management
Sood, K., & Shanavas, A. (2021) · Current Pathobiology Reports · doi:10.1007/s40139-021-00222-4 · Cited by 11
Zhao, D., Gao, L., Huang, X., Chen, G., Gao, B., Wang, J., Gu, M., & Wang, F. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133371 · Cited by 10
Tasleem, M. W., Rajpoot, S. R., & Zhang, H. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125816 · Cited by 10
Aptamers in Combination Therapies for Enhanced Radiosensitization in Cancer.
Bemidinezhad, A., Abolhassani, Y., Tabrizi, A. S., Karimabad, M. N., Parsa‐kondelaji, M., Roshani, R., & Gheybi, F. (2025) · PubMed Central · doi:10.30498/ijb.2025.491856.4032 · Cited by 11
Rasouli, N., Shahbazi‐Gahrouei, D., Hematti, S., Baradaran, B., Salehi, R., Varshosaz, J., & Jafarizad, A. (2022) · Polymers · doi:10.3390/polym14194131 · Cited by 10
“Ghahremani and coworkers found that the size of the nanoparticles has a major role in radiosensitization: namely, ultrasmall size causes a high surface-to-volume ratio and can lead to an increase in the interaction of radiation beams and nanoparticles [28].”
BackgroundSelf-citationLiu, S., Wang, J., Song, Y., He, S., & Tan, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112451 · Cited by 10
131I-Caerin 1.1 and 131I-Caerin 1.9 for the treatment of non-small-cell lung cancer
Liu, N., He, T., Xiao, Z., Du, J., Zhu, K., Liu, X., Chen, T., Liu, W., Ni, G., Liu, X., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.861206 · Cited by 9
Sobhani, T., Shahbazi‐Gahrouei, D., Zahraei, M., Hejazi, S. H., Dousti, F., & Rostami, M. R. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04427-x · Cited by 8
Self-citationNanoscaled biphasic calcium phosphate modulates osteogenesis and attenuates LPS-induced inflammation
Su, Y.-C., Phan, T. T. T., Wang, T., Chang, S., Lin, F., Hsu, T.-S., & Lin, L. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1236429 · Cited by 7
Gold nanoclusters in cancer drug delivery: Advances and emerging applications
Singh, J., Alruwaili, N. K., Aodah, A. H., Almalki, W. H., Almujri, S. S., Alrobaian, M., Rab, S. O., Alanezi, A. A., Haji, E. M., Barkat, M. A., et al. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106594 · Cited by 6
Golden era of radiosensitizers
Čížková, J., Dolezal, O. J., Buchta, V., Pospichal, J., Blanař, V., Šinkorová, Z., & Lierová, A. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1450776 · Cited by 6
Synthesis and sensing applications of metal nanoclusters: a frontier to cancer diagnostics
Mansoor, T., Dabur, D., Wu, H.-F., & Shiue, Y.-L. (2025) · Nanoscale · doi:10.1039/d5nr03510d · Cited by 5
Kefayat, A., Yuosefzadeh, M., Goli, P., Babayi, A., Rezaei, A., & Esmaeil, N. (2021) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.30476/mejc.2020.83064.1130 · Cited by 5
Self-citationPandey, S. K., Mradula, M., & Santhanam, M. (2023) · Current Cancer Therapy Reviews · doi:10.2174/1573394719666230911113126 · Cited by 5
Kozani, P. S., Kozani, P. S., & Rahbarizadeh, F. (2021) · Trends in Medical Sciences · doi:10.5812/tms.113991 · Cited by 5
Domínguez, A., Navarro, N., Aviñó, A. M., Fàbrega, C., & Eritja, R. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2659926 · Cited by 4
Realizing active targeting in cancer nanomedicine with ultrasmall nanoparticles
Lima, A. F., Justo, G. Z., & Sousa, A. A. (2024) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.15.98 · Cited by 4
Sood, K., Yadav, P., Jamwal, M., Das, R., & Shanavas, A. (2023) · Nanotheranostics · doi:10.7150/ntno.82978 · Cited by 4
Asadpour, S., Saberi, Z., & Naderi, M. (2024) · Dyes and Pigments · doi:10.1016/j.dyepig.2024.112273 · Cited by 4
Musarrat, N., Fatima, M., Batool, Z., Imran, M., Jabeen, Q., Ahmad, H. E., Manzoor, M. Z., Abbas, S. M., Saira, F., Ihsan, M. U., et al. (2024) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2024.129686 · Cited by 4
Kefayat, A., Molaabasi, F., Bahrami, M., Karami, M., Mirzadeh, M., Askari, E., Hajian, A., Ghahremani, F. H., Mirzavandi, Z., Rafienia, M., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03854-5 · Cited by 3
“At the 3rd day after the cancer cells injection, mice were divided into four groups ( n = 8) including (1) Control, (2) Dox (5 mg/kg, twice a week for 2 weeks according to previous studies [19]), (3) Dox@HA-FA (10 mg/kg, twice a week for 2 weeks, (4) Gel/PCL/HA-Dox@ HAP-FA scaffolds.”
Self-citationTheranostic gold nanoparticle-assisted tumor radiosensitization and imaging
Hara, D., Schmidt, R. M., Tao, W., Yang, Y., Dogan, N., Daunert, S., Polack, A., Ford, J. C., & Shi, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19061-2.00001-8 · Cited by 3
Bioavailability, biodistribution, and toxicity of fluorescent metal nanoclusters
Kefayat, A., & Molaabasi, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88657-4.00009-0 · Cited by 3
Self-citationLunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
“Early studies predominantly investigated relatively simple high-Z nanostructures designed primarily to maximize physical dose enhancement through radiation energy deposition [30,64,65].”
Peptide- and Protein-Based Nanoparticles
Negah, S. S., Khawaja, A. M., Kendall, L., & Heiss, J. D. (2024) · Springer eBooks · doi:10.1007/978-3-030-80662-0_5 · Cited by 2
Nano MgO: A Promising Biocompatible Candidate in the Modern Medicinal Field
(2025) · Biointerface Research in Applied Chemistry · doi:10.33263/briac152.021 · Cited by 2
“…age-related muscular degeneration), nucleolin-targeting AS1411 polymeric system are two examples (myeloid leukemia, glioma, and breast cancer) [159], EpCAM-conjugated PEI nanoparticles (breast and retinoblastoma tumors) [160], A10 RNA aptamer-linked PLGA-PEG particles (targeting prostate…”
Rashid, A., Krishnan, A., Gupta, S., Gupta, J. C., & Talwar, G. P. (2025) · Medical Oncology · doi:10.1007/s12032-025-03152-y · Cited by 1
DNA Aptamers: Reloaded Tools for Breast Cancer Therapeutics
Carrasco-Maure, K., Gonzalez-Olivares, M., & Lobos‐González, L. (2026) · Cancers · doi:10.3390/cancers18050766 · Cited by 1
“The AS1411 aptamer, directed against nucleolin (NCL), inhibits cell proliferation and enhances radiosensitivity when combined with gold nanoparticles, being one of the first aptamers evaluated clinically [55,56].”
Yang, Z., Yang, A., Ma, W., Ma, K., Lv, Y.-K., Peng, P., Zang, S., & Li, B. (2022) · Figshare · doi:10.6084/m9.figshare.17983031
Využití nanotechnologií v radiační onkologii
Buchta, V. (2023) · Digital library - University of Pardubice (University of Pardubice)
Messina, R., Bellucci, L., Corni, S., Cascino, L., Rivalta, I., D’Agostino, S., & Polzi, L. Z. (2026) · Nanoscale · doi:10.1039/d6nr00330c
Li, R., Gao, R., Zhao, Y., Zhang, F., Wang, X., Li, B., Wang, L., Ma, L., & Du, J. (2022) · doi:10.3389/fonc.2022.930920.s001
Su, Y.-C., Phan, T. T. T., Wang, T.-W., Chang, S.-H., Lin, F.-H., Hsu, T.-S., & Lin, L.-Y. (2023) · doi:10.3389/fbioe.2023.1236429.s009
Metadata
- Authors
- Ghahremani, F., Kefayat, A., Shahbazi-Gahrouei, D., Motaghi, H., Mehrgardi, M. A., & Haghjooy-Javanmard, S.
- Affiliations
- Isfahan University of Medical Sciences (IR)
- Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran
- University of Isfahan (IR)
- Department of Physiology, Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan, 81746-73461, Iran
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2018-10
- Volume
- 13
- Issue
- 20
- Pages
- 2563-2578
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2896171835
- Cited by
- 70
- References
- 53
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 11 · 2023: 7 · 2022: 15 · 2021: 12 · 2020: 6 · 2019: 8
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nanomedicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Materials Science › Materials Chemistry › Nanocluster Synthesis and Applications
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- AS1411 aptamer, gold nanoclusters, radiosensitizers, radiotherapy, breast cancer, tumor targeting, cellular uptake, tumor volume, biocompatibility, nanoparticle drug delivery
- MeSH terms
- Animals, Breast Neoplasms, Female, Flow Cytometry, Humans, Oligodeoxyribonucleotides, Radiation-Sensitizing Agents, Drug Delivery Systems, Cell Line, Tumor, Mice, Aptamers, Nucleotide, Metal Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.